2Yoshioka K, Kakumu S, Arao M, et al. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease[ J]. Hepatology, 1989,10:769.
3Pinzani M, Milani S, De Franco R , et al. Endothelin-1 is expressed in human cirrhotic liver and exerts muitiple effects on activated hepatic stellate cells [ J ]. Gastroenterol, 1996,110: 534 -548.
4Rockey DC, Weisiger RA. Endothelin antagnism in experimental hepatic fibrosis:Implication for endothelin in the pathogenesis of wound healing[J]. Hepatology, 1996,24:233 - 240.
1Schrier RW, Arroyo V, Bemardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis [J]. Hepatology, 1988,8 ( 5 ) : 1151 - 7.
3Laffi G. Villa G, Gentilini P. Pathogenesis and management of the hepatorenal syndrome [ J ]. Semin Liver Dis, 1994,14 ( 1 ) : 71 - 81.
4Tily H, Willmer A, Vogel W. Serum levels of cytok ines in ch runic liver disease [ J ]. Gastroenterology, 1992, 103 ( 1 ) : 264 - 74.
5Mookerjee RP, Sen S, Davies NA, et al. Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis[J ]. Gut, 2003, 52 ( 8 ) : 1182 - 7.
6Piepot HA, Groeneveld AB, van Lambalgen AA, et al. Tumor necrosis factor - alpha impairs endothelium - dependent relaxation of rat renal arteries, independent of tyrosine kinase [J]. Shock, 2002,17 (5):394 -8.
7Donnahoo KK, Shames BD, Harken AH, et al. Review article: the role of tumor necrosis factor in renal ischemia - reperfusion injury[J]. J Urol, 1999, 162( 1 ): 196 -203.
8Stark ME, Bauer AJ, Sarr MG, et al. Nitric oxide mediates inhibitory nerve input in human and canine jejunum [J]. Gastroenterology, 1993, 104(2):398-409.
9Poole S, Bird TA, Selkirk S, et al. Fate of injected interleukin 1 in rats: sequestration and degradation in the kidney [J]. Cytokine, 1990,2(6):416 -22.
